Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: Aids clinical trials group study A5199, the international neurological study

Clinical Infectious Diseases

Volumn 55, Issue 6, 2012, Pages 868-876

  Robertson, K ^a   Jiang, H ^b   Kumwenda, J ^c   Supparatpinyo, K ^d   Evans, S ^b   Campbell, T B ^e   Price, R ^f   Tripathy, S ^g   Kumarasamy, N ^h   La Rosa, A ⁱ   Santos, B ^j,k   Silva, M T ^l   Montano, S ^i,m   Kanyama, C ⁿ   Faesen, S ^o   Murphy, R ^p   Hall, C ^l   Marra, C M ^q   Marcus, C ^a   Berzins, B ^p   Allen, R ^r   Housseinipour, M ⁿ   Amod, F ^s   Sanne, I ^o   Hakim, J ^t   Walawander, A ^u   Nair, A ^u   more..

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b HARVARD UNIVERSITY   (United States)

^c QUEEN ELIZABETH CENTRAL HOSPITAL   (Malawi)

^d CHIANG MAI UNIVERSITY   (Thailand)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NATIONAL AIDS RESEARCH INSTITUTE   (India)

^h VHS Medical Centre India   (India)

ⁱ ASOCIACIÓN CIVIL IMPACTA SALUD Y EDUCACIÓN   (Peru)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^k HOSPITAL NOSSA SENHORA DA CONCEIÇÃO   (Brazil)

^l INSTITUTO OSWALDO CRUZ   (Brazil)

^m California   (Peru)

ⁿ Kamuza Central Hospital   (Malawi)

^o HELEN JOSEPH HOSPITAL   (South Africa)

^p NORTHWESTERN UNIVERSITY   (United States)

^q UNIVERSITY OF WASHINGTON   (United States)

^r Social Scientific Systems   (United States)

^s UNIVERSITY OF KWAZULU NATAL   (South Africa)

^t UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^u FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR; DIDANOSINE; EFAVIRENZ; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; EMTRICITABINE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; FEMALE; FINGER TAPPING TEST; GROOVED PEGBOARD TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEMANTIC VERBAL FLUENCY; TIMED GAIT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS DEMENTIA COMPLEX; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV-1; HUMANS; MALE; NEUROLOGIC EXAMINATION; PSYCHOLOGICAL TESTS; TREATMENT OUTCOME;

EID: 84865482221     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis507     Document Type: Article

References (26)

1. World Health Organization. Global summary of the HIV/AIDS epidemic, December 2003. Geneva, Switzerland: World Health Organization, December 2003.
2. Price RW, Spudich SJ. Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis 2008; 197(Supp 3): S294-306. (Pubitemid 351717319)
3. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69:1789-99. (Pubitemid 350059308)
4. American Academy of Neurology. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a working group of the American academy of neurology AIDS task force. Neurology 1991; 41:778-85.
5. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986; 19:517-24. (Pubitemid 16085185)
6. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: neuropathology. Ann Neurol 1986; 19:525-35.
7. McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort study. Neurology 1993; 43:2245-52. (Pubitemid 23346956)
8. Robertson KR, Hall CD. HIV related mild cognitive impairment and AIDS dementia complex. Semin Neurol 1992; 12:18-27.
9. Elder GA, Sever JL. AIDS and neurological disorders: an overview. Ann Neurol 1988; 23:S4-S6.
10. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents, recommendations for a public health approach: 2010 revision, 2010.
11. Price RW, Sidtis JJ. Evaluation of the AIDS dementia complex in clinical trials. J AIDS 1990; 3(Supp 2):S51-60.
12. Sidtis JJ, Gatsonis C, Price RW, et al. Zidovudine treatment of the AIDS dementia complex: results of a placebo controlled trial. AIDS Clinical Trials Group. Ann Neurol 1993; 33:343-9. (Pubitemid 23103965)
13. Letendre S. Revised CNS penetration-effectiveness ranks. In: 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, 2010.
14. Robertson K, Kumwenda J, Supparatpinyo K, et al. The AIDS Clinical Trials Group. A multinational study of neurological performance in antiretroviral therapy-naive HIV-1-infected persons in diverse resource-constrained settings. J Neurovirol 2011 Jul 23. [Epub ahead of print] PMID:21786076.
15. Gendleman H, Zheng J, Coulter C, et al. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in HIV-associated dementia. J Infect Dis 1998; 178:1000-7. (Pubitemid 28452191)
16. McArthur JC, Haughey N, Gartner S, et al. HIV associated dementia: a evolving disease. J Neurovirol 2003; 9:205-21.
17. Robertson K, Robertson W, Ford S, Watson D, Fiscus S, Harp A, Hall C. Highly active antiretroviral therapy improves neurocognitive function. J AIDS 2004; 36:562-66. (Pubitemid 38544504)
18. Sacktor N, McDermott MP, Marder K, et al. HIV-1 associated cognitive impairment before and after the advent of combination therapy. J. Neurovirol 2002; 8:136-42. (Pubitemid 34520894)
19. Maj M, Satz P, Janssen R, et al. WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psyc 1994; 51:51-61. (Pubitemid 24028998)
20. Sacktor N, Nakasujja N, Skolasky RL, et al. HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 2009; 49:780-6.
21. Jowi JO, Mativo PM, Musoke SS. Clinical and laboratory characteristics of hospitalised patients with neurological manifestations of HIV/AIDS at the Nairobi hospital. East Afr Med J 2007; 84:67-76.
22. Mielke J. Neurological complications of human immunodeficiency virus infection in Zimbabwe-2005. J Neurovirol. 2005; 11(Suppl 3): 23-5.
23. Parry O, Mielke J, Latif AS, Ray S, Levy LF, Siziya S. Peripheral neuropathy in individuals with HIV infection in Zimbabwe. Acta Neurol Scand 1997; 96:218-22. (Pubitemid 27402489)
24. Robertson K, Liner J, Hakim J, et al. NeuroAIDS in Africa Conference Participants. NeuroAIDS in Africa. J Neurovirol 2010; 16:189-202. Review. PMID: 20500018.
25. Robertson K, Liner J, Heaton R. Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev 2009; 19:232-49.
26. Wright EJ, Nunn M, Joseph J, Robertson K, Lal L, Brew BJ. Neuro-AIDS in the Asia pacific region. J Neurovirol 2008; 14:465-73.